systemic lupus erythematosus

27
Naomi Sen

Upload: sumi

Post on 21-Jan-2016

115 views

Category:

Documents


1 download

DESCRIPTION

Systemic Lupus Erythematosus. Naomi Sen. Aims and Objectives. Aim To give an outline of the diagnosis and management of SLE Objectives To describe signs and symptoms of SLE To outline relevant investigations To describe management of SLE. Outline. Pathogenesis - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Systemic Lupus  Erythematosus

Naomi Sen

Page 2: Systemic Lupus  Erythematosus

Aim◦ To give an outline of the diagnosis and

management of SLE

Objectives◦ To describe signs and symptoms of SLE◦ To outline relevant investigations◦ To describe management of SLE

Page 3: Systemic Lupus  Erythematosus

Pathogenesis Epidemiology and risk factors Presentation Investigations Associated illnesses Management Pregnancy and fertility Prognosis Summary

Page 4: Systemic Lupus  Erythematosus

SLE is a heterogeneous, inflammatory, multisystem autoimmune disease in which antinuclear antibodies occur.

Page 5: Systemic Lupus  Erythematosus

SLE is a heterogeneous,

inflammatory, multisystem

autoimmune disease in which

antinuclear antibodies occur. Failure to clear apopetic material efficiently Anti-Ro and Anti–La widespread vasculitis

Page 6: Systemic Lupus  Erythematosus
Page 7: Systemic Lupus  Erythematosus

Prevalence : 50-100/100000 Peak onset 20-40y Female : Male 9:1 Chinese, Southeast Asian (1 in 1000) and

Afro-Caribbean (1 in 500) most common Least common in Northern European origin

(1 in 2800)

Page 8: Systemic Lupus  Erythematosus

Genetic◦ HLA-B8 and DR3 in caucasians, (DR2 in Japanese)

Complement◦ Defective C4 gene

Environmental◦ EBV◦ UV light◦ Drugs:

Chlorpromazine Isoniazid Methyldopa d-penicillamine Hyrdalazine Minocycline

Page 9: Systemic Lupus  Erythematosus
Page 10: Systemic Lupus  Erythematosus

Relapsing and remitting Non-specific

◦ Fatigue◦ Malaise◦ Arthralgia◦ Lymphadenopathy◦ Fever

Page 11: Systemic Lupus  Erythematosus

Joints and Muscles ◦ Most common clinical feature◦ Symmetrical small joint arthralgia

Clinically normal examination Skin

◦ Butterfly erythema◦ Vasculitic lesions on fingertips and nail folds◦ Purpura and urticaria◦ 1/3 - photosensitivity

Page 12: Systemic Lupus  Erythematosus

Lungs ◦ Pleurisy◦ Recurrent pleural effusions (exudate)

Cardiovascular◦ Pericarditis◦ Mild myocarditis =/- arrhythmias◦ Raynaud’s◦ Arterial and venous thromboembolism –

antiphospholipid syndrome◦ Atherosclerotic disease

Page 13: Systemic Lupus  Erythematosus

Kidneys◦ glomerulonephritis

CNS◦ Depression◦ Epilepsy◦ Migraine◦ Hemiplegia◦ Ataxia◦ Psychosis◦ Demyelinating syndromes

Page 14: Systemic Lupus  Erythematosus

Eyes◦ Retinal vasculitis hard exudates and

haemorrhages◦ Episcleritis/conjunctivitis/optic neuritis

GI◦ Mouth ulcers◦ Abdominal pain – mesenteric vasculitis

inflammation perforation or infarction

Page 15: Systemic Lupus  Erythematosus

DOPAMINE RASH – 4 out of 11◦ Discoid Rash◦ Oral Ulcers◦ Photosensitivity◦ Arthritis◦ Malar rash◦ Immunological – anti ro, la, smith, dsDNA◦ Neurological changes◦ Elevated ESR◦ Renal involvement◦ ANA +ve◦ Serositis (plurisy and pericarditis)◦ Haematological (haemolytic anaemia, ↓WCC↓plt)

Page 16: Systemic Lupus  Erythematosus
Page 17: Systemic Lupus  Erythematosus

Histology◦ Skin biopsies◦ Renal biopsies

Imaging ◦ CT◦ MRI

Page 18: Systemic Lupus  Erythematosus

Antiphospholipid syndrome Overlap syndromes: scleroderma, polymyositis,

rheumatoid arthritis and Sjögren's syndrome Prone to other autoimmune conditions such as

thyroiditis Higher incidence of drug allergy Increased risk of infection Increased risk atherosclerosis, hypertension,

dyslipidaemias, diabetes, osteoporosis, avascular necrosis and malignancies (especially non-Hodgkin's lymphoma)

Page 19: Systemic Lupus  Erythematosus

Individual counselling Avoid sun exposure , use sunscreen Analgesia – caution with NSAIDs Corticosteroids – effecitive – but s/e Hydroxychloroquine Cyclphosphamide – life threatening Azothioprine – steroid sparing Methotrexate

Page 20: Systemic Lupus  Erythematosus

Barrier methods of contraception -safest Oestrogens can exacerbate lupus Lowest dose COCP can be used with caution

if no◦ Migraines◦ Thrombosis◦ Hypertension◦ Anticardiolipin antibodies are negative

Increased risk of thrombosis – needs to be counselled.

Page 21: Systemic Lupus  Erythematosus

Fertility is normal Pregnancy is safe in mild or stable disease In severe lupus – disease should be controlled

prior to pregnancy Morbidity - ↑if antiphospholipid antibodies

◦ Recurrent miscarriage◦ Pre-eclampsia◦ IUGR◦ Premature delivery◦ Thrombosis◦ Worsening or renal disease and hypertension

LMWH and low dose aspirin treatment of choice

Page 22: Systemic Lupus  Erythematosus

Improved with earlier recognition and improved management.◦ Morbidity and mortality – higher in patients with

extensive multisystem disease and multiple auto antibodies

◦ Renal involvement poorer prognosis◦ Drug induced lupus usually subsides when the

drug is discontinued.

Page 23: Systemic Lupus  Erythematosus

SLE is a heterogeneous, inflammatory, multisystem autoimmune disease in which

antinuclear antibodies occur. More common in females in their 20-40s More common in Asian and Afro-Caribbean

populations

Page 24: Systemic Lupus  Erythematosus

Relapsing remitting Diagnosis – 4 out of 11 “DOPAMINE RASH” Multiple systems – most common – joint

pain

Initial investigations – Bloods - FBC, ESR, CRP, Complement, ANA, RF, Immunoglobulins, Antiphospholipid antibodies

Page 25: Systemic Lupus  Erythematosus

Management◦ Individual◦ Sunscreen◦ Analgesia◦ Steroids and immunosuppression if severe◦ Contraception if severe

Barrier – fewer risks than hormonal◦ If antiphospholipid

LMWH and aspirin in pregnancy

Page 26: Systemic Lupus  Erythematosus
Page 27: Systemic Lupus  Erythematosus

www.patient.co.uk Kumar and Clarke

Also Wikipedia and Dr Google!